Abstract-Platelets constitutively express class B scavenger receptors CD36 and SR-BI, 2 closely related pattern recognition receptors best known for their roles in lipoprotein and lipid metabolism. The biological role of scavenger receptors in platelets is poorly understood. However, in vitro and in vivo data suggest that class B scavenger receptors modulate platelet function and contribute significantly to thrombosis by sensing pathological or physiological ligands, inducing prothrombotic signaling, and increasing platelet reactivity. Platelet CD36 recognizes a novel family of endogenous oxidized choline phospholipids that accumulate in plasma of hyperlipidemic mice and in plasma of subjects with low high-density lipoprotein levels. This interaction leads to the activation of specific signaling pathways and promotes platelet activation and thrombosis. Platelet SR-BI, on the other hand, plays a critical role in the induction of platelet hyperreactivity and accelerated thrombosis under conditions associated with increased platelet cholesterol content. Intriguingly, oxidized high-density lipoprotein, an SR-BI ligand, can suppress platelet function. These recent findings demonstrate that platelet class B scavenger receptors play roles in thrombosis in dyslipidemia and may contribute to acute cardiovascular events in vivo in hypercholesterolemia. Key Words: lipids Ⅲ lipoproteins Ⅲ oxidized lipids Ⅲ platelets Ⅲ signal transduction S cavenger receptors (SR) are a group of structurally heterologous cell surface receptors that share an ability to recognize chemically modified or oxidized forms of lowdensity lipoprotein (LDL). SR belong to a wider family of pattern recognition receptors that mediate the innate immune host response which includes Toll-like receptors. Platelets express several SR including class B SR CD36 and SR-BI, 2 closely related multiligand receptors, best known for their roles in lipoprotein and lipid metabolism. 1 Other platelet SR include LOX-1 and CD68. 1 Expression of class B SR in platelets is mainly constitutive, whereas other receptors are rapidly exposed on platelet activation. Ligands for these receptors can be roughly divided into 3 groups: physiological ligands, pathological endogenous (changed self) ligands, and pathological exogenous ligands. Pathological endogenous ligands for platelet SR may be present in circulation in a number of pathophysiological states related to dyslipidemia and oxidative stress. Pathological exogenous ligands may be present in cases of infections. The biological role of SR in platelets is not understood yet. However, evidence is accumulating that SR contribute significantly to thrombosis by sensing pathological or physiological ligands, inducing prothrombotic signaling, and increasing platelet reactivity. This in turn may lead to thrombosis in the presence of threshold concentrations of agonists. Platelet hyperreactivity or increased platelet response to agonists is associated with augmented platelet adhesion, integrin activation, and aggregation. [2][3][4] Subj...